Burger - Figure 30
10 year cystectomy rates
FIG. 30: In North America and the European Union about 2% of all bladder cancer cases are considered to be adenocarcinoma, but there is a higher rate of glandular differentiation in some 50%.[7,11] One subgroup, urachal carcinoma, comprises some 10% of all adenocarcinomas.[18] These patients with urachal carcinomas are usually younger, and almost half of them are female.
References
Klaile Y, Schlack K, Boegemann M, et al. Variant histology in bladder cancer: how it should change the management in non-muscle invasive and muscle invasive disease? Transl Androl Urol. 2016;5:692−701 https://dx.doi.org/10.21037%2Ftau.2016.06.13
Humphrey PA, Moch H, Cubilla AL The 2016 WHO classification of tumours of the urinary system and male genital organs-Part B: Prostate and bladder tumours. Eur Urol. 2016;70:106−19 http://dx.doi.org/10.1016/j.eururo.2016.02.028
Wright JL, Porter MP, Li CI, et al. Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder. Cancer. 2006;107:721−8 https://doi.org/10.1002/cncr.22059
